Fmr LLC Buys 380,626 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

FMR LLC increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 9.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,216,835 shares of the real estate investment trust's stock after acquiring an additional 380,626 shares during the period. FMR LLC owned approximately 1.56% of Omega Healthcare Investors worth $171,625,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of OHI. Versant Capital Management Inc acquired a new stake in Omega Healthcare Investors in the second quarter valued at $26,000. UMB Bank n.a. boosted its holdings in Omega Healthcare Investors by 353.4% in the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. acquired a new stake in Omega Healthcare Investors in the 3rd quarter valued at about $33,000. V Square Quantitative Management LLC raised its holdings in shares of Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock worth $40,000 after acquiring an additional 323 shares during the last quarter. Finally, Truvestments Capital LLC purchased a new stake in shares of Omega Healthcare Investors during the third quarter worth about $43,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Down 0.6 %

Shares of NYSE:OHI traded down $0.25 during mid-day trading on Tuesday, reaching $39.56. 636,637 shares of the stock were exchanged, compared to its average volume of 1,681,723. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.68 billion, a P/E ratio of 29.27, a P/E/G ratio of 1.26 and a beta of 0.98. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42. The stock's 50 day simple moving average is $40.59 and its 200-day simple moving average is $37.46.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.77%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 197.06%.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on OHI shares. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Berenberg Bank began coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They set a "buy" rating and a $45.00 price objective on the stock. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research note on Wednesday, September 4th. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Finally, Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a report on Monday, August 26th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.